Go to main content
 
DH hosts international conference on pharmaceutical regulation showcasing Hong Kong's regulatory capabilities (with photos)
******************************************************************************************
     The "2025 Pharmaceutical Inspection Co-operation Scheme (PIC/S) Seminar" commenced today (November 5) in Hong Kong. This annual gathering of global pharmaceutical regulatory authorities, co-organised by the Department of Health (DH) and the Pharmacy and Poisons Board of Hong Kong (the Board) this year, runs for three days. It has drawn over 160 Good Manufacturing Practice (GMP) inspectors and experts responsible for regulating pharmaceutical manufacturing from over 50 pharmaceutical regulatory authorities and organisations worldwide. Participants engaged in in-depth discussions and shared experiences on the latest developments and regulatory frameworks in three key emerging pharmaceutical fields, namely artificial intelligence, continuous manufacturing and point-of-care manufacturing, which decentralises drug production to sites closer to patients, such as hospitals.

     Selecting Hong Kong as this year's host venue fully affirms the city's advantage of being highly internationalised and its high standards of pharmaceutical regulation.

     The Director of Health, Dr Ronald Lam, said in his opening remarks, "Hong Kong, China is committed to upholding international best practices in pharmaceutical regulation to safeguard public health. Since becoming a member of the PIC/S a decade ago, we have gained invaluable knowledge from fellow inspectors and experts through annual seminars, Expert Circles, and the PIC/S Inspectorates' Academy. This has enhanced the capabilities of our inspectors responsible for regulating drug manufacturing and ensured the quality of medicines for the public. Every PIC/S member shares a common mission to uphold GMP standards and actively safeguard public health. This is also the cornerstone of Hong Kong, China's advancement as an international health and medical innovation hub."

     "The Chief Executive announced in the 2025 Policy Address the setting up of the 'Hong Kong Centre for Medical Products Regulation' (CMPR) in 2026. Our vision is to develop the CMPR into a robust, internationally recognised regulatory authority. It will not only strengthen our regulatory framework but will also actively promote medical innovation. To realise this forward-looking vision, we have proposed 'Advanced Technologies in Pharmaceutical Manufacturing' as the theme for this year's Seminar in order to advance global pharmaceutical regulation," Dr Lam added.

     "I am proud and honoured to open this 2025 PIC/S seminar in the wonderful city of Hong Kong. It is my second venue here, and I am again impressed by Hong Kong's professionalism and the efficiency in hosting one of the most important annual PIC/S events. As Chair of the Committee of Officials, I would like to deeply thank the DH and the Board for organising this meeting, which will be, I am sure, a great success. It will be another occasion for GMP inspectors to meet, learn as well as share experiences in order to improve the quality of medicinal products and, so, to protect public health", the Chairperson of the PIC/S, Mr Jacques Morénas, said at the opening ceremony.

     The PIC/S has been established for over 50 years as a renowned international organisation comprising pharmaceutical regulatory authorities from multiple countries and regions, currently with 56 participating authorities. Its mission is to lead the international development, formulate standards for implementation, and adherence to harmonised GMP standards and quality systems among pharmaceutical regulatory authorities. After the PIC/S's deliberation in 2015, Hong Kong, China formally joined as a member, signifying that the quality of local pharmaceutical manufacturing has gained international recognition and is on par with global standards and regulations.
 
Ends/Wednesday, November 5, 2025
Issued at HKT 15:00
NNNN
Archives   Yesterday's Press Releases  
Back to Index Page
Back to top
Today's Press Releases  

Photo

The "2025 Pharmaceutical Inspection Co-operation Scheme (PIC/S) Seminar" commenced today (November 5) in Hong Kong. This annual gathering of global pharmaceutical regulatory authorities, co-organised by the Department of Health and the Pharmacy and Poisons Board of Hong Kong this year, runs for three days. It has drawn over 160 Good Manufacturing Practice inspectors and experts responsible for regulating pharmaceutical manufacturing from over 50 pharmaceutical regulatory authorities and organisations worldwide. Photo shows the Director of Health, Dr Ronald Lam, delivering opening remarks.
The "2025 Pharmaceutical Inspection Co-operation Scheme (PIC/S) Seminar" commenced today (November 5) in Hong Kong. This annual gathering of global pharmaceutical regulatory authorities, co-organised by the Department of Health and the Pharmacy and Poisons Board of Hong Kong this year, runs for three days. It has drawn over 160 Good Manufacturing Practice inspectors and experts responsible for regulating pharmaceutical manufacturing from over 50 pharmaceutical regulatory authorities and organisations worldwide. Photo shows the Director of Health, Dr Ronald Lam (front row, third right); the Controller of Regulatory Affairs of the Department of Health, Dr Fung Ying (front row, second right); the Chairperson of the PIC/S, Mr Jacques Morénas (front row, third left), and other attendees of the seminar.
The "2025 Pharmaceutical Inspection Co-operation Scheme (PIC/S) Seminar" commenced today (November 5) in Hong Kong. This annual gathering of global pharmaceutical regulatory authorities, co-organised by the Department of Health and the Pharmacy and Poisons Board of Hong Kong this year, runs for three days. It has drawn over 160 Good Manufacturing Practice inspectors and experts responsible for regulating pharmaceutical manufacturing from over 50 pharmaceutical regulatory authorities and organisations worldwide. Photo shows the Director of Health, Dr Ronald Lam (front row, fifth left); the Controller of Regulatory Affairs of the Department of Health, Dr Fung Ying (front row, sixth left); the Chairperson of the PIC/S, Mr Jacques Morénas (front row, fourth left), and other attendees of the seminar.